Presentation TCT 2017 Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR? Presenter: David H. Adams, Ted Feldman, Vinod H. Thourani October 30, 2017
Presentation TCT 2016 Rationale for and Design of GALILEO Presenter: Michael Argenziano, Alec S. Vahanian, Paul Sorajja October 31, 2016
Presentation TCT 2015 Adjunctive Pharmacotherapy During and After TAVR: BRAVO 3, GALILEO, and Beyond Presenter: Ganesh Manoharan, Mathew Williams, Torsten P. Vahl October 15, 2015